Stay updated on Pembrolizumab vs Paclitaxel in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Paclitaxel in Gastric Cancer Clinical Trial page.

Latest updates to the Pembrolizumab vs Paclitaxel in Gastric Cancer Clinical Trial page
- Check7 days agoChange DetectedGastric cancer is now listed as a related topic. A Genetic and Rare Diseases Information Center resources entry is shown under Resources.SummaryDifference0.2%

- Check14 days agoChange DetectedA new site revision (v3.4.2) was added and a government funding status notice (v3.4.1) was removed; these appear to be maintenance updates that do not affect the study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedA site-wide notice about government funding delays and the NIH Clinical Center status was added. The site revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded: Show glossary; Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0. Deleted: Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page shows Revision: v3.3.4, replacing Revision: v3.3.3.SummaryDifference0.1%

- Check64 days agoChange DetectedAdministrative updates: added Revision: v3.3.3 and removed HHS Vulnerability Disclosure along with Revision: v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab vs Paclitaxel in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Paclitaxel in Gastric Cancer Clinical Trial page.